Propanc Biopharma

Company snapshot

Propanc Biopharma is a biotech organization headquartered in CAMBERWELL, VICTORIA, C3, USA. It trades on NYSE under ticker PPCB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 3 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 3 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Propanc Biopharma. Not investment advice.

• What is Propanc Biopharma?

  Propanc Biopharma is a biotech organization headquartered in CAMBERWELL, VICTORIA, C3, USA. It trades on NYSE under ticker PPCB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 3 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPT

• Is Propanc Biopharma publicly traded?

  Yes. Propanc Biopharma is listed with ticker PPCB on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Propanc Biopharma develop or market?

  No drug profiles are currently linked to Propanc Biopharma. Pipeline programs may still list investigational assets.

• What are the latest developments for Propanc Biopharma?

  In the last 12 months our linked public records show 0 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does Propanc Biopharma focus on?

  No specific therapeutic focus areas are currently identified for Propanc Biopharma in our database.